The novel, non-balloon catheter comprises part of the company’s first-of-its-kind forward intravascular lithotripsy (IVL) platform. It features a similar safety and effectiveness profile to legacy Shockwave IVL catheters. The system aims to modify calcium and cross significantly narrowed vessels in patients with peripheral artery disease (PAD).

Santa Clara, California-based Shockwave designed Javelin with a single 120-pulse lithotripsy emitter at the distal tip of the catheter. The company developed it for use in sub-total occlusions or significantly narrowed vessels. These are vessels in which a wire can cross but devices can not. With this new platform, the sonic pressure waves expand spherically from the forward-shifted emitter beyond the tip of the catheter. It allows modification of the obstructive calcification that facilitates device crossing.